Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'VLASUK GP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bergum, PW; Cruikshank, A; Maki, SL; Kelly, CR; Ruf, W; Vlasuk, GP
      Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    2. Friederich, PW; Levi, M; Bauer, KA; Vlasuk, GP; Rote, WE; Breederveld, D; Keller, T; Spataro, M; Barzegar, S; Buller, HR
      Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects

      CIRCULATION
    3. Inan, M; Chiruvolu, V; Eskridge, KM; Vlasuk, GP; Dickerson, K; Brown, S; Meagher, MM
      Optimization of temperature-glycerol-pH conditions for a fed-batch fermentation process for recombinant hookworm (Ancylostoma caninum) anticoagulant peptide (AcAP-5) production by Pichia pastoris

      ENZYME AND MICROBIAL TECHNOLOGY
    4. VLASUK GP
      NOVEL ANTICOAGULANTS - OVERVIEW

      Coronary artery disease
    5. VLASUK GP
      THE NEW ANTICOAGULANTS - NEW OPPORTUNITIES, NEW ISSUES

      Archives of pathology and laboratory medicine
    6. VLASUK GP; BERGUM PW; ROTE WE; RUF W
      MECHANISTIC AND PHARMACOLOGICAL EVALUATION OF NAPC2, A NOVEL SMALL PROTEIN INHIBITOR OF THE FACTOR VIIA TISSUE FACTOR COMPLEX

      Thrombosis and haemostasis
    7. REBELLO SS; BLANK HS; ROTE WE; VLASUK GP; LUCCHESI BR
      ANTITHROMBOTIC EFFICACY OF A RECOMBINANT NEMATODE ANTICOAGULANT PEPTIDE (RNAP5) IN CANINE MODELS OF THROMBOSIS AFTER SINGLE SUBCUTANEOUS ADMINISTRATION

      The Journal of pharmacology and experimental therapeutics
    8. BETZ A; VLASUK GP; BERGUM PW; KRISHNASWAMY S
      SELECTIVE-INHIBITION OF THE PROTHROMBINASE COMPLEX - FACTOR VA ALTERSMACROMOLECULAR RECOGNITION OF A TICK ANTICOAGULANT PEPTIDE MUTANT BY FACTOR XA

      Biochemistry
    9. VLASUK GP; BERGUM PW; BRADBURY AE; LOYNDS P; MANT TGK; ROTE WE
      CLINICAL-EVALUATION OF RNAPC2, AN INHIBITOR OF THE FVIIA TISSUE FACTOR COAGULATION COMPLEX/

      The American journal of cardiology
    10. KRISHNAN R; TULINSKY A; VLASUK GP; PEARSON D; VALLAR P; BERGUM P; BRUNCK TK; RIPKA WC
      SYNTHESIS, STRUCTURE, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DIVALENT THROMBIN INHIBITORS CONTA AN ALPHA-KETO-AMIDE TRANSITION-STATE MIMETIC

      Protein science
    11. ROTE WE; DEMPSEY E; MAKI S; VLASUK GP; MOYLE M
      THE ROLE OF CD11 CD18 INTEGRINS IN THE REVERSE PASSIVE ARTHUS REACTION IN RAT DERMAL TISSUE/

      Journal of leukocyte biology
    12. STANSSENS P; BERGUM PW; GANSEMANS Y; JESPERS L; LAROCHE Y; HUANG S; MAKI S; MESSENS J; LAUWEREYS M; CAPPELLO M; HOTEZ PJ; LASTERS I; VLASUK GP
      ANTICOAGULANT REPERTOIRE OF THE HOOKWORM ANCYLOSTOMA-CANINUM

      Proceedings of the National Academy of Sciences of the United Statesof America
    13. MAKI SL; RUF W; HUANG S; KELLY C; VLASUK GP
      NEMATODE ANTICOAGULANT PROTEIN C2 (C2) - A POTENT INHIBITOR OF FACTORVIIA TISSUE FACTOR COMPLEX (FVIIA/TF) REQUIRES AN EXOSITE ON FACTOR XA (FXA) THAT OVERLAPS A FACTOR VA (FVA) BINDING-SITE/

      Circulation
    14. ROTE WE; OLDESCHULLE GL; DEMPSEY EM; VLASUK GP
      EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF THE BLOOD-COAGULATION FACTOR VIIA TISSUE FACTOR COMPLEX IN ANIMAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS/

      Circulation
    15. BERKELEY CJ; VLASUK GP; ROTE WE
      COMPARISON OF NEMATODE ANTICOAGULANT PROTEINS (NAPS) WITH LOW-MOLECULAR-WEIGHT HEPARIN IN A MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION(DIC)

      Circulation
    16. COUSINS GR; FRIEDRICHS GS; SUDO Y; REBELLO SS; ROTE WE; VLASUK GP; NOLAN TG; MENDOZA C; LUCCHESI BR
      ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS DOG

      Circulation
    17. BIEMOND BJ; FRIEDERICH PW; LEVI M; VLASUK GP; BULLER HR; TENCATE JW
      COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS

      Circulation
    18. ORVIM U; BARSTAD RM; VLASUK GP; SAKARIASSEN KS
      EFFECT OF SELECTIVE FACTOR XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR VIIA OR COLLAGEN IN AN EX-VIVO MODEL OF SHEAR-DEPENDENT HUMAN THROMBOGENESIS/

      Arteriosclerosis, thrombosis, and vascular biology
    19. LYLE EM; FUJITA T; CONNER MW; CONNOLLY TM; VLASUK GP; LYNCH JL
      EFFECT OF INHIBITORS OF FACTOR X(A) OR PLATELET-ADHESION, HEPARIN, AND ASPIRIN ON PLATELET DEPOSITION IN AN ATHEROSCLEROTIC RABBIT MODEL OFANGIOPLASTY INJURY

      Journal of pharmacological and toxicological methods
    20. LIMWILBY MSL; HALLENGA K; DEMAEYER M; LASTERS I; VLASUK GP; BRUNCK TK
      NMR STRUCTURE DETERMINATION OF TICK ANTICOAGULANT PEPTIDE (TAP)

      Protein science
    21. JESPERS LS; MESSENS JH; DEKEYSER A; EECKHOUT D; VANDENBRANDE I; GANSEMANS YG; LAUWEREYS MJ; VLASUK GP; STANSSENS PE
      SURFACE EXPRESSION AND LIGAND-BASED SELECTION OF CDNAS FUSED TO FILAMENTOUS PHAGE GENE VI

      Bio/technology
    22. LYNCH JJ; SITKO GR; LEHMAN ED; VLASUK GP
      PRIMARY PREVENTION OF CORONARY ARTERIAL THROMBOSIS WITH THE FACTOR XAINHIBITOR RTAP IN A CANINE ELECTROLYTIC INJURY MODEL

      Thrombosis and haemostasis
    23. ORVIM U; BARSTAD RM; VLASUK GP; SAKARIASSEN KS
      EFFECT OF SELECTIVE FACTOR-XA INHIBITION ON ARTERIAL THROMBUS FORMATION TRIGGERED BY TISSUE FACTOR FACTOR-VIIA AND COLLAGEN IN AN EX-VIVO MODEL OF HUMAN SHEAR-DEPENDENT THROMBOGENESIS

      Thrombosis and haemostasis
    24. VLASUK GP; BERGUM PW; BRUNCK TK; CAPPELLO M; DEMPSEY EM; GANSEMANS Y; HERMAN S; HOTEZ PJ; HUANG S; LAROCHE Y; LASTERS I; LAUWEREYS M; MAKI S; MESSENS J; PERSIAU G; ROTE WE; STANSSENS P; VANHOUTVEN A
      ANTICOAGULANT REPERTOIRE OF HEMATOPHAGOUS NEMATODES

      Thrombosis and haemostasis
    25. CAPPELLO M; VLASUK GP; BERGUM PW; HUANG S; HOTEZ PJ
      ANCYLOSTOMA-CANINUM ANTICOAGULANT PEPTIDE - A HOOKWORM-DERIVED INHIBITOR OF HUMAN COAGULATION-FACTOR XA

      Proceedings of the National Academy of Sciences of the United Statesof America
    26. COUSINS GR; FRIEDRICHS GS; SUDO YJ; ROTE WE; VLASUK GP; NOLAN T; MENDOZA C; LUCCHESI BR
      ORALLY EFFECTIVE CVS-1123 PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CONSCIOUS CANINE

      Circulation
    27. ROTE WE; VLASUK GP
      EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN A PORCINE MODEL OF ACUTE CORONARY-ARTERY THROMBOSIS

      Circulation
    28. VLASUK GP; DEMPSEY EM; OLDESCHULTE GL; BERNARDINO VT; RICHARD BM; ROTE WE
      EVALUATION OF A NOVEL SMALL PROTEIN INHIBITOR OF BLOOD-COAGULATION FACTOR XA (RNAP-5) IN ANIMAL-MODELS OF THROMBOSIS

      Circulation
    29. BERGUM PW; MAKI SL; HUANG S; BENHAM PP; VLASUK GP
      THE ANTICOAGULANT STRATEGY OF THE HOOKWORM A-CANINUM - POTENT INHIBITION OF HUMAN-FACTORS XA (FXA) AND VIIA TF BY A UNIQUE MECHANISM USING FX AND FXA/

      Blood
    30. MOYLE M; FOSTER DL; MCGRATH DE; BROWN SM; LAROCHE Y; DEMEUTTER J; STANSSENS P; BOGOWITZ CA; FRIED VA; ELY JA; SOULE HR; VLASUK GP
      A HOOKWORM GLYCOPROTEIN THAT INHIBITS NEUTROPHIL FUNCTION IS A LIGANDOF THE INTEGRIN CD11B CD18

      The Journal of biological chemistry
    31. RICHARD BM; NOLAN TG; TRAN HS; MILLER MM; NUTT RF; VLASUK GP
      BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION

      Circulation
    32. RICHARD BM; NOLAN TG; TRAN HS; MILLER MM; NUTT RF; VLASUK GP
      BIOAVAILABILITY OF A NOVEL DIRECT THROMBIN INHIBITOR IN NONHUMAN-PRIMATES FOLLOWING ORAL-ADMINISTRATION

      Circulation
    33. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
      EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS

      Circulation
    34. ROTE WE; DEMPSEY EM; OLDESCHULTE GL; ARDECKY RJ; TAMURA SY; NUTT RF; BERGUM PW; TRAN HS; ANDERSON SM; VLASUK GP
      EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS

      Circulation
    35. VLASUK GP; VALLAR PL; WEINHOUSE MI; BERGUM PW; TRAN HS; WEITZ JI; TULINSKY A; KRISHNAN R; ROFE WE; OLDESCHULTE GL; PEARSON DA
      A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC

      Circulation
    36. VLASUK GP; VALLAR PL; WEINHOUSE MI; BERGUM PW; TRAN HS; WEITZ JI; TULINSKY A; KRISHNAN R; ROFE WE; OLDESCHULTE GL; PEARSON DA
      A NOVEL INHIBITOR OF THROMBIN CONTAINING MULTIPLE RECOGNITION SEQUENCES LINKED BY A ALPHA-KETO AMIDE TRANSITION-STATE MIMETIC

      Circulation
    37. RAGOSTA M; GIMPLE LW; GERTZ SD; DUNWIDDIE CT; VLASUK GP; HABER HL; POWERS ER; ROBERTS WC; SAREMBOCK IJ
      SPECIFIC FACTOR XA INHIBITION REDUCES RESTENOSIS AFTER BALLOON ANGIOPLASTY OF ATHEROSCLEROTIC FEMORAL ARTERIES IN RABBITS

      Circulation
    38. LYNCH JJ; SITKO GR; MELLOTT MJ; NUTT EM; LEHMAN ED; FRIEDMAN PA; DUNWIDDIE CT; VLASUK GP
      MAINTENANCE OF CANINE CORONARY-ARTERY PATENCY FOLLOWING THROMBOLYSIS WITH FRONT LOADED PLUS LOW-DOSE MAINTENANCE CONJUNCTIVE THERAPY - A COMPARISON OF FACTOR XA VERSUS THROMBIN INHIBITION

      Cardiovascular Research
    39. KRISHNASWAMY S; VLASUK GP; BERGUM PW
      ASSEMBLY OF THE PROTHROMBINASE COMPLEX ENHANCES THE INHIBITION OF BOVINE FACTOR XA BY TICK ANTICOAGULANT PEPTIDE

      Biochemistry
    40. VLASUK GP
      STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF TICK ANTICOAGULANT PEPTIDE (TAP) - A POTENT AND SELECTIVE INHIBITOR OF BLOOD-COAGULATION FACTOR XA

      Thrombosis and haemostasis
    41. LAUWEREYS M; STANSSENS P; LAMBEIR AM; MESSENS J; DEMPSEY E; VLASUK GP
      ECOTIN AS A POTENT FACTOR-XA INHIBITOR

      Thrombosis and haemostasis
    42. BERGUM PW; VLASUK GP; KRISHNASWAMY S
      FACTOR-VA(FVA) STABILIZES THE INHIBITORY COMPLEX BETWEEN TICK ANTICOAGULANT PROTEIN (TAP) AND FACTOR-XA (FXA)

      Thrombosis and haemostasis
    43. MELLOTT MJ; STRANIERI MT; SITKO GR; STABILITO II; LYNCH JJ; VLASUK GP
      ENHANCEMENT OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR-INDUCED REPERFUSION BY RECOMBINANT TICK ANTICOAGULANT PEPTIDE, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS

      Fibrinolysis
    44. BERGUM PW; MAKI SL; HUANG S; VLASUK GP
      A MONOCLONAL-ANTIBODY (CVS-12D10) AGAINST HUMAN FACTOR-VII VIIA THAT INHIBITS THE ACTIVATION OF BOTH FACTOR-IX AND FACTOR-X/

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 05:19:32